Elsevier

Elsevier operates a content and data platform business model built around proprietary scholarly and clinical information and associated analytics. It creates value by acquiring, curating and hosting peer-reviewed journals, books, abstracts and domain-specific datasets (for example in chemistry and biomedicine), and by layering search, discovery, evaluation and decision-support tools on top. These assets are bundled into platforms for research, analytics, and clinical workflows, which are sold to institutions and enterprises. The company deepens lock-in through integrated suites (research discovery, performance analytics, research information management, clinical reference) and by acquiring complementary workflow tools and communities, then connecting them to its content and data. Value for customers centres on reliable access to literature, performance measurement, compliance and support for R&D and clinical decisions.

Elsevier is a Netherlands-based subsidiary of RELX that operates as a global scholarly and clinical publisher and provider of research and analytics platforms. It manages large databases of peer-reviewed journals, books and abstracts, as well as specialised tools for bibliometrics, chemistry, and clinical decision support.

The company generates revenue primarily from institutional subscriptions, site licences and enterprise SaaS agreements with universities, research institutions, hospitals, corporations and funders. Additional income comes from article processing charges for open-access publishing, data and API licensing, professional services, and some pay-per-view content access. End users are researchers, clinicians and students, but the paying customers are mainly institutions and enterprises.